borderline significanceP = 0.069
Similarly, there was borderline significance between median TTR for patients with low ZNF24 expression (median TTR, 29.0 months) and those with high ZNF24 expression (median TTR, 41.0 months; log-rank P = 0.069).
Similarly, there was borderline significance between median TTR for patients with low ZNF24 expression (median TTR, 29.0 months) and those with high ZNF24 expression (median TTR, 41.0 months; log-rank P = 0.069).
The difference in overall survival (OS) for patients with high and low miR-940 expression failed to reach statistical significance (log-rank P = 0.139).
Univariate analyses revealed that low expression of ZNF24 was significantly associated with decreased OS and had a borderline significant association with decreased TTR (Figure 4C and Table 2 ).